Why CRISPR Therapeutics Stock Just Popped Another 5%
CRISPR Therapeutics (NASDAQ: CRSP) stock is hot this week, after the biotech presented four research posters at the American Association for Cancer Research's Virtual Meeting II this week, offering preclinical data on its gene-editing cancer research and sparking a flurry of supportive notes from Wall Street.
CRISPR stock is up a solid 4.5% as of 2:55 p.m. EDT today and, added to yesterday's gains, has risen more than 9% over the past two days.
Image source: Getty Images.
Source Fool.com
